Eggermont C - Search Results

1

Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer.

Giron P, Eggermont C, Noeparast A, Vandenplas H, Teugels E, Forsyth R, De Wever O, Aza-Blanc P, Gutierrez GJ, De Grève J. Giron P, et al. Among authors: eggermont c. Int J Cancer. 2021 May 15;148(10):2579-2593. doi: 10.1002/ijc.33404. Epub 2021 Jan 25. Int J Cancer. 2021. PMID: 33210294 Free PMC article.

2

Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer.

Noeparast A, Giron P, De Brakeleer S, Eggermont C, De Ridder U, Teugels E, De Grève J. Noeparast A, et al. Among authors: eggermont c. Oncotarget. 2018 Feb 27;9(22):16110-16123. doi: 10.18632/oncotarget.24576. eCollection 2018 Mar 23. Oncotarget. 2018. PMID: 29662630 Free PMC article.

3

CRAF mutations in lung cancer can be oncogenic and predict sensitivity to combined type II RAF and MEK inhibition.

Noeparast A, Giron P, Noor A, Bahadur Shahi R, De Brakeleer S, Eggermont C, Vandenplas H, Boeckx B, Lambrechts D, De Grève J, Teugels E. Noeparast A, et al. Among authors: eggermont c. Oncogene. 2019 Aug;38(31):5933-5941. doi: 10.1038/s41388-019-0866-7. Epub 2019 Jul 8. Oncogene. 2019. PMID: 31285551 Free PMC article.

4

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.

Eggermont C, Giron P, Noeparast M, Vandenplas H, Aza-Blanc P, Gutierrez GJ, De Grève J. Eggermont C, et al. Cell Death Dis. 2022 Jul 15;13(7):611. doi: 10.1038/s41419-022-04994-4. Cell Death Dis. 2022. PMID: 35840561 Free PMC article.

5

Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib.

Eggermont C, Gutierrez GJ, De Grève J, Giron P. Eggermont C, et al. Cancers (Basel). 2023 May 2;15(9):2589. doi: 10.3390/cancers15092589. Cancers (Basel). 2023. PMID: 37174055 Free PMC article.

6

Shifting landscape in skin cancer incidence: the rising tide of cutaneous squamous cell carcinoma and potential implications for prevention.

Eggermont CJ, Eggermont AMM. Eggermont CJ, et al. Br J Dermatol. 2024 Mar 15;190(4):460-461. doi: 10.1093/bjd/ljad480. Br J Dermatol. 2024. PMID: 38099564 No abstract available.

7

Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.

Eggermont CJ, Hollestein LM, Hollatz A, Louwman M, Mooyaart AL, Nijsten T, Wakkee M. Eggermont CJ, et al. J Am Acad Dermatol. 2024 Mar;90(3):530-536. doi: 10.1016/j.jaad.2023.10.036. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871807 Free article.

8

The impact of routine ultrasonography on nodal metastasis in head and neck cutaneous squamous cell carcinoma: A retrospective multicentre cohort study.

Eggermont C, Nené LEH, Koekelkoren FHJ, van der Toorn YR, Snetselaar LD, Kroah-Hartman M, Genders RE, Kelleners-Smeets NWJ, Hollestein LM, van Kester MS, Wakkee M. Eggermont C, et al. J Eur Acad Dermatol Venereol. 2023 Sep;37(9):e1136-e1140. doi: 10.1111/jdv.19150. Epub 2023 May 6. J Eur Acad Dermatol Venereol. 2023. PMID: 37114343 No abstract available.

9

Development and Validation of an Algorithm to Identify Patients with Advanced Cutaneous Squamous Cell Carcinoma from Pathology Reports.

Eggermont C, Wakkee M, Bruggink A, Voorham Q, Schreuder K, Louwman M, Mooyaart A, Hollestein L. Eggermont C, et al. J Invest Dermatol. 2023 Jan;143(1):98-104.e5. doi: 10.1016/j.jid.2022.07.008. Epub 2022 Aug 1. J Invest Dermatol. 2023. PMID: 35926654 Free article.

10

Association Between Abdominal Aortic Calcification, Bone Mineral Density, and Fracture in Older Women.

Lewis JR, Eggermont CJ, Schousboe JT, Lim WH, Wong G, Khoo B, Sim M, Yu M, Ueland T, Bollerslev J, Hodgson JM, Zhu K, Wilson KE, Kiel DP, Prince RL. Lewis JR, et al. Among authors: eggermont cj. J Bone Miner Res. 2019 Nov;34(11):2052-2060. doi: 10.1002/jbmr.3830. Epub 2019 Oct 9. J Bone Miner Res. 2019. PMID: 31310354 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page